Clinical trials: Frozen Shoulder
Adhesive Capsulitis, Frozen Shoulder
Safety and Efficacy of EN3835 in Participants With Frozen Shoulder
This study will evaluate the safety and efficacy of EN3835 for the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
- Trial name
- NCT04496167
- Testing
- EN3835
- Where
- 38 sites in United States
- Volunteers
- 198 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
- Trial name
- NCT01483963
- Testing
- AA4500 0.29 mg/1 mL, AA4500 0.58 mg/2 mL, AA4500 0.58 mg/1 mL
- Where
- 15 sites in United States
- Volunteers
- 50 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
- Trial name
- AC (NCT02006719)
- Testing
- Collagenase Clostridium Histolyticum
- Where
- 46 sites in United States, Australia
- Volunteers
- 322 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company